- Contact us
- Contact us
About UsHistory
Established Biospace Co., Ltd.
- Successfully commercialized the world's first body composition analyzer by launching InBody2.0
- Dr. Kichul Cha, founder of InBody Co., Ltd succeeded in overcoming the limitations of conventional body composition analysis technology and created the world's first body composition analysis device that was high in accuracy and reproducibility.
- This was a great significance for the Korean Technology as it prepared and created a platform for Korean standard technology to be used worldwide.
Established Bioengineering
research center
Established subsidiary
office in the US and Japan
InBody has been actively in the international market from the beginning. InBody has educated and trained their employees as a product expert so that they can start pioneering and developing a market that never existed, and enlightening the customers.
Cheon-An Factory completed
Unified all Body Composition
Analyzer Brands as InBody series
- Launched the Home-use body
composition analyzer for home healthcare - To enter into the B2C market and divesity new product line, we launched a home-use body composition analyzer.
- We prepared and expanded into the market by marketing the idea that it’s important to cumulatively manage your body composition rather than being a substitute of a weight scale.
Established a subsidiary office in China
Awarded the 10 Million Dollar
Export Tower on Trade Day
Changed the company
name as "InBody Co., Ltd."
Established Subsidiary office
in Malaysia (InBody Asia) & India(InBody India)
Established Subsidiary Office in
Netherlands (InBody Europe)
Expansion of the Cheonan Production Factory
(floors with 22,480 square meter(m2))
InBody Sphygmomanometer 'BPBIO320'
passed the clinical test of the European Society of
Hypertension (ESH) for the first time in Korea
Established a subsidiary office in Mexico
